GB8608309D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB8608309D0
GB8608309D0 GB868608309A GB8608309A GB8608309D0 GB 8608309 D0 GB8608309 D0 GB 8608309D0 GB 868608309 A GB868608309 A GB 868608309A GB 8608309 A GB8608309 A GB 8608309A GB 8608309 D0 GB8608309 D0 GB 8608309D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB868608309A
Other versions
GB2173401B (en
GB2173401A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poli Industria Chimica SpA
Original Assignee
Poli Industria Chimica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Industria Chimica SpA filed Critical Poli Industria Chimica SpA
Publication of GB8608309D0 publication Critical patent/GB8608309D0/en
Publication of GB2173401A publication Critical patent/GB2173401A/en
Application granted granted Critical
Publication of GB2173401B publication Critical patent/GB2173401B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08608309A 1985-04-04 1986-04-04 Pharmaceutical compositions for the treatment of cerebrovascular and aging brain disorders Expired GB2173401B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20241/85A IT1200609B (en) 1985-04-04 1985-04-04 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CEREBROVASCULAR TURBES AND THE ELDERLY BRAIN

Publications (3)

Publication Number Publication Date
GB8608309D0 true GB8608309D0 (en) 1986-05-08
GB2173401A GB2173401A (en) 1986-10-15
GB2173401B GB2173401B (en) 1988-10-12

Family

ID=11165058

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08608309A Expired GB2173401B (en) 1985-04-04 1986-04-04 Pharmaceutical compositions for the treatment of cerebrovascular and aging brain disorders

Country Status (5)

Country Link
JP (1) JPS61289031A (en)
DE (1) DE3525389A1 (en)
FR (1) FR2579892A1 (en)
GB (1) GB2173401B (en)
IT (1) IT1200609B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08102263A (en) * 1994-08-05 1996-04-16 Japan Atom Energy Res Inst Gyrotron device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2735587A1 (en) * 1977-08-06 1979-02-15 Sandoz Ag STABLE SOLUTIONS AND METHOD FOR THEIR PRODUCTION
FI761461A (en) * 1975-05-31 1976-12-01 Sandoz Ag
DE2930369A1 (en) * 1979-07-26 1981-02-05 Rentschler Arzneimittel MEDICINE SOLUTIONS
DE3227122A1 (en) * 1982-07-20 1984-01-26 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim STABLE SOLUTIONS OF MOTHER CORNAL CALOIDS

Also Published As

Publication number Publication date
IT1200609B (en) 1989-01-27
FR2579892A1 (en) 1986-10-10
JPS61289031A (en) 1986-12-19
GB2173401B (en) 1988-10-12
GB2173401A (en) 1986-10-15
IT8520241A0 (en) 1985-04-04
DE3525389A1 (en) 1986-10-09

Similar Documents

Publication Publication Date Title
GB8626808D0 (en) Pharmaceutical compositions
GB8524001D0 (en) Pharmaceutical composition
GB2174904B (en) Vasculoprotecting pharmaceutical compositions
GB8602787D0 (en) Pharmaceutical composition
GB8602788D0 (en) Pharmaceutical composition
GB8621577D0 (en) Pharmaceutical compositions
GB8530796D0 (en) Pharmaceutical composition
GB2171600B (en) Pharmaceutical compositions
GB8602625D0 (en) Pharmaceutical compositions
GB8618820D0 (en) Pharmaceutical compositions
EP0197752A3 (en) Pharmaceutical compositions
GB8618249D0 (en) Pharmaceutical compositions
GB8515170D0 (en) Pharmaceutical compositions
GB8602602D0 (en) Pharmaceutical compositions
GB8607848D0 (en) Pharmaceutical compositions
GB8618590D0 (en) Pharmaceutical compositions
GB2182561B (en) Pharmaceutical compositions
GB8610970D0 (en) Pharmaceutical compositions
GB8618589D0 (en) Pharmaceutical compositions
GB8522327D0 (en) Pharmaceutical compositions
GB8602601D0 (en) Pharmaceutical compositions
GB8523531D0 (en) Pharmaceutical compositions
GB8608310D0 (en) Pharmaceutical compositions
GB8502887D0 (en) Pharmaceutical compositions
GB8608309D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee